Who has invested in Tarveda Therapeutics?

Versant Ventures, New Enterprise Associates, Novo A/S, NanoDimension, Flagship Pioneering are named among the investors backing Tarveda Therapeutics.

Tarveda Therapeutics Funding: $68M Raised, Series D (2017)

Tarveda Therapeutics funding overview

Tarveda Therapeutics is based in Watertown, Massachusetts. Tarveda Therapeutics has raised $68M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in February 2017. The round record for Tarveda Therapeutics runs through 2017; nothing later has been disclosed. Investors on record include Versant Ventures, New Enterprise Associates, Novo A/S, NanoDimension, Flagship Pioneering. 5 distinct backers are named across the disclosed rounds.

Tarveda Therapeutics at a glance

Total raised: $68M
Latest round: Series D
Latest round date: February 2017
Headquarters: Watertown, Massachusetts
Notable investors: Versant Ventures, New Enterprise Associates, Novo A/S, NanoDimension, Flagship Pioneering

Frequently asked about Tarveda Therapeutics funding

How much has Tarveda Therapeutics raised?: Tarveda Therapeutics has raised $68M in total disclosed funding across the rounds on record.
Who has invested in Tarveda Therapeutics?: Versant Ventures, New Enterprise Associates, Novo A/S, NanoDimension, Flagship Pioneering are named among the investors backing Tarveda Therapeutics.
What was the latest Tarveda Therapeutics funding round?: The most recent disclosed round is a Series D, announced in February 2017.
Where is Tarveda Therapeutics based?: Tarveda Therapeutics is based in Watertown, Massachusetts.
When did Tarveda Therapeutics last raise?: The last disclosed Tarveda Therapeutics round closed in February 2017 at Series D.

Round data for Tarveda Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Watertown and backer lists below.

Tarveda Therapeutics Funding: $68M Raised, Series D (2017)

Tarveda Therapeutics funding overview

Tarveda Therapeutics at a glance

Frequently asked about Tarveda Therapeutics funding

Companies related to Tarveda Therapeutics (36)

Browse related funding lists (6)